Skip to content

Edwards Lifesciences EW Other Working Capital

Other Working Capital at other companies

Abbott logo
AbbottABT
$420M-3.7%
Artivion logo
ArtivionAORT
$537K+119%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$314K-103%
ICU Medical logo
ICU MedicalICUI
-$2.99M+67.6%
Boston Scientific logo
Boston ScientificBSX
$27M+486%
Medtronic logo
MedtronicMDT
$727M+20.0%

Other financials

Income statement

See full
Revenue$1.6B+16.7%
Gross profit$1.3B+15.7%
Operating income$477.6M+21.0%
Net income$380.7M+6.3%
EPS (diluted)$0.66+8.2%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$52.09B+20.1%
Enterprise value$50.34B+23.3%
P/E47.5×+37.1×
P/S8.3×+0.6×

Profitability

See full
Gross margin77.9%-1.6pp
Operating margin21.4%-4.4pp
Net margin17.4%-58.3pp
FCF margin17.3%

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's other working capital?
Edwards Lifesciences (EW) reported other working capital of $18.1M in Q1 2026.
How has Edwards Lifesciences's other working capital changed year-over-year?
Edwards Lifesciences's other working capital decreased by 36.7% year-over-year, from $28.6M to $18.1M.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.